Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuronetics Q2 EPS $(0.15) Misses $(0.08) Estimate, Sales $38.108M Beat $36.612M Estimate

Author: Benzinga Newsdesk | August 05, 2025 06:06am
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.08) by 94.81 percent. This is a 54.55 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $38.108 million which beat the analyst consensus estimate of $36.612 million by 4.08 percent. This is a 131.66 percent increase over sales of $16.450 million the same period last year.

Posted In: STIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist